Search

everythinglearnresearchcommunity

for

Search:↓

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

The traditional treatment was more effective than finasteride for androgenic alopecia.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

The new gel formulation effectively delivers Finasteride for hair growth treatment without skin irritation.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Fermented red ginseng marc may help treat atopic dermatitis by reducing inflammation and improving skin health.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Targeting FGF5 could help treat prostate cancer.

Epidermal growth factor helps hair recover after chemotherapy.

High-dose iron therapy improves anemia without affecting IBD treatment.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Many patients with Giant Cell Arteritis did not follow their steroid treatment plans properly.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Taking riboflavin and eating less lysine can help some people with a specific genetic disorder avoid brain damage.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Low-level laser therapy reduces symptoms and inflammation in frontal fibrosing alopecia.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Erbium-YAG laser treatment improved folliculitis decalvans without causing hair loss.

The cream effectively reduced hair growth on forearms.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

GDNF signaling helps in hair growth and skin healing after a wound.